Effect of high-flow nasal oxygen on falls among cancer survivors
Published
May 4, 2024
Paper ID
PAP-000017
Status
Published
DOI
10.65712/tmj.test000275
Advance Services
Abstract
Background: The cost of falls to health systems is substantial. Methods: The primary outcome was falls, assessed blind to allocation. Results: 2923 participants were included (median age 35 years). Serious adverse events were rare and similar between groups. Conclusion: Strengths include the sample size and blinded outcome assessment.
References
1. Zhang B, Rossi Z, et al. Delayed cord clamping and surgical site infection. Ann Intern Med. 2016;225(9):335-1214.
2. Haddad G, Lindqvist U, et al. Home-based cardiac rehabilitation and acute kidney injury. Ann Intern Med. 2014;63(2):702-1130.
3. Haddad A, Mensah E, et al. SGLT2 inhibitors and time to diagnosis. Ann Intern Med. 2025;278(1):792-1758.
4. Costa S, Tanaka Z, et al. A sepsis alert system and emergency department revisits. BMJ. 2012;167(8):494-931.
5. Kim C, Herrera Q, et al. Low-dose aspirin and post-operative delirium. Diabetes Care. 2015;17(4):653-929.
6. Mueller P, Rahman N, et al. Prone positioning and in-hospital mortality. Lancet. 2012;182(6):587-1075.
7. Lindqvist X, Larsen F, et al. Vitamin D supplementation and ventilator-free days. Crit Care Med. 2018;374(7):201-1322.
8. Kim P, Yilmaz F, et al. Machine-learning triage and patient satisfaction. Pediatrics. 2012;128(8):150-1710.
Introduction
Practice around high-flow nasal oxygen varies widely between centres. The cost of falls to health systems is substantial.
Earlier studies of high-flow nasal oxygen were small or single-centre. Practice around high-flow nasal oxygen varies widely between centres.
falls remains a leading cause of avoidable harm among cancer survivors. The cost of falls to health systems is substantial.
Materials and Methods
Analyses were adjusted for age, sex and baseline severity. We conducted a case series across 14 centres between 2015 and 2021.
The primary outcome was falls, assessed blind to allocation. Analyses were adjusted for age, sex and baseline severity.
Results
The adjusted odds ratio was 0.47 (95% CI 0.37 to 0.72). 1647 participants were included (median age 65 years).
Serious adverse events were rare and similar between groups. The adjusted odds ratio was 0.81 (95% CI 0.24 to 0.76). The adjusted odds ratio was 0.74 (95% CI 0.49 to 0.90). 3680 participants were included (median age 33 years).
| Group | n | Events | Rate % | OR | 95% CI |
|---|---|---|---|---|---|
| Female | 110 | 110 | 30.5 | 0.55 | 0.45–1.23 |
| Centre A | 125 | 42 | 11.3 | 0.90 | 0.35–1.24 |
| Age < 65 | 508 | 12 | 40.0 | 0.43 | 0.28–1.34 |
| Age ≥ 65 | 871 | 27 | 14.3 | 0.55 | 0.50–1.8 |
| Age < 65 | 738 | 63 | 37.6 | 0.45 | 0.25–1.34 |
| Female | 478 | 7 | 10.0 | 0.63 | 0.52–1.3 |
| Male | 548 | 35 | 16.3 | 0.80 | 0.31–1.22 |
Values are n (%) unless stated otherwise.

Shown for cancer survivors; error bars are 95% confidence intervals.

Shown for cancer survivors; error bars are 95% confidence intervals.
Effects were consistent across prespecified subgroups.
Discussion
These findings suggest that high-flow nasal oxygen is associated with better falls in cancer survivors. Future work should test high-flow nasal oxygen in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols.
Implementation will depend on staffing, cost and local protocols. These findings suggest that high-flow nasal oxygen is associated with better falls in cancer survivors. Strengths include the sample size and blinded outcome assessment.
Conclusions
High-flow nasal oxygen is a reasonable option for cancer survivors to improve falls.
Appendices
Supplementary tables are available on request.